Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Gemcitabine-induced thrombotic microangiopathy: a systematic review.

Izzedine H, Isnard-Bagnis C, Launay-Vacher V, Mercadal L, Tostivint I, Rixe O, Brocheriou I, Bourry E, Karie S, Saeb S, Casimir N, Billemont B, Deray G.

Nephrol Dial Transplant. 2006 Nov;21(11):3038-45. Epub 2006 Sep 12. Review. No abstract available.

PMID:
16968717
2.

Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.

Flombaum CD, Mouradian JA, Casper ES, Erlandson RA, Benedetti F.

Am J Kidney Dis. 1999 Mar;33(3):555-62.

PMID:
10070921
3.

Gemcitabine-associated thrombotic microangiopathy.

Humphreys BD, Sharman JP, Henderson JM, Clark JW, Marks PW, Rennke HG, Zhu AX, Magee CC.

Cancer. 2004 Jun 15;100(12):2664-70.

4.

Gemcitabine-induced thrombotic microangiopathy.

Richmond J, Gilbar P, Abro E.

Intern Med J. 2013 Nov;43(11):1240-2. doi: 10.1111/imj.12261.

PMID:
24237646
5.

[Gemcitabine-induced thrombotic microangiopathy].

Teixeira L, Debourdeau P, Zammit C, Estival JL, Pavic M, Colle B.

Presse Med. 2002 Apr 27;31(16):740-2. Review. French.

PMID:
12148351
6.

The cumulative incidence of gemcitabine-induced thrombotic microangiopathy.

Arnadottir M, Benediktsson T, Hrafnkelsson J.

Acta Oncol. 2007;46(4):545-6. No abstract available.

PMID:
17497322
7.

Gemcitabine-related thrombotic microangiopathy: a single-centre retrospective series.

Leal F, Macedo LT, Carvalheira JB.

J Chemother. 2014 Jun;26(3):169-72. doi: 10.1179/1973947813Y.0000000122. Epub 2013 Dec 6.

PMID:
24091354
8.

Gemcitabine-induced hemolytic uremic syndrome: a case report.

Brodowicz T, Breiteneder S, Wiltschke C, Zielinski CC.

J Natl Cancer Inst. 1997 Dec 17;89(24):1895-6. No abstract available.

PMID:
9414181
9.

Thrombotic microangiopathy with renal failure in two patients undergoing gemcitabine chemotherapy.

Lhotta K, Kühr T, Rumpelt HJ, Wöll E, Thaler J, König P.

Am J Nephrol. 1999;19(5):590-3.

PMID:
10575189
10.

Gemcitabine: vascular toxicity and prothrombotic potential.

Dasanu CA.

Expert Opin Drug Saf. 2008 Nov;7(6):703-16. doi: 10.1517/14740330802374262 . Review.

PMID:
18983217
11.

Gemcitabine-associated livedoid thrombotic microangiopathy with associated sclerema neonatorum-like microscopic changes.

Mir-Bonafé JM, Román-Curto C, Santos-Briz A, Cañueto J, Fernández-López E, Unamuno P.

J Cutan Pathol. 2012 Jul;39(7):707-11. doi: 10.1111/j.1600-0560.2012.01918.x. Epub 2012 May 22.

PMID:
22612305
12.

Chronic thrombotic microangiopathy secondary to chemotherapy for urothelial carcinoma in a patient with a history of Wegener granulomatosis.

Thomas JG, Sethi S, Norby SM.

Am J Kidney Dis. 2011 May;57(5):799-802. doi: 10.1053/j.ajkd.2011.01.017. Epub 2011 Mar 15.

PMID:
21411201
13.
14.

Development of thrombotic thrombocytopenic purpura after a single dose of gemcitabine.

De Smet D, Jochmans K, Neyns B.

Ann Hematol. 2008 Jun;87(6):495-6. Epub 2007 Dec 21. No abstract available.

PMID:
18097666
15.

Thrombotic microangiopathy and digital necrosis: two unrecognized toxicities of gemcitabine.

Vénat-Bouvet L, Ly K, Szelag JC, Martin J, Labourey JL, Genet D, Tubiana-Mathieu N.

Anticancer Drugs. 2003 Nov;14(10):829-32.

PMID:
14597878
16.

[Hemolytic-uremic syndrome complicating a long-term treatment with gemcitabine. Report of a case and review of the literature].

Dilhuydy MS, Delclaux C, Pariente A, De Precigout V, Aparicio M.

Rev Med Interne. 2002 Feb;23(2):189-92. Review. French.

PMID:
11876063
17.

[Digital ischaemia and gemcitabine. Two new cases].

Blaise S, Appeltants H, Carpentier PH, Debru JL.

J Mal Vasc. 2005 Feb;30(1):53-7. Review. French.

PMID:
15924070
18.

[Is the frequency of hemolytic uremic syndrome as a complication of gemcitabine underestimated? The role of systematic screening].

Desramé J, Duvic C, Béchade D, Bredin C, Raynaud JJ, Defuentes G, Dourthe LM, Algayres JP.

Gastroenterol Clin Biol. 2006 Feb;30(2):332-4. French. No abstract available.

19.

Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution.

Müller S, Schütt P, Bojko P, Nowrousian MR, Hense J, Seeber S, Moritz T.

Ann Hematol. 2005 Feb;84(2):110-4. Epub 2004 Sep 1.

PMID:
15340761
20.

Thrombotic microangiopathy in a sirolimus-treated renal transplant patient receiving gemcitabine for lung cancer.

Courtellemont C, Guitard J, Mehrenberger M, Pontier S, Ribes D, Kamar N, Esposito L, Modesto A, Rostaing L.

Clin Nephrol. 2007 Feb;67(2):114-8.

PMID:
17338432

Supplemental Content

Support Center